# Safety and Pharmacokinetics Study of HRS-1893 Tablets in Healthy Subjects and Those With Impaired Kidney Function

> **NCT06775834** · PHASE1 · COMPLETED · sponsor: **Shandong Suncadia Medicine Co., Ltd.** · enrollment: 24 (actual)

## Conditions studied

- Hypertrophic Cardiomyopathy

## Interventions

- **DRUG:** HRS-1893

## Key facts

- **NCT ID:** NCT06775834
- **Lead sponsor:** Shandong Suncadia Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-02-11
- **Primary completion:** 2025-07-23
- **Final completion:** 2025-07-23
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2025-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06775834

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06775834, "Safety and Pharmacokinetics Study of HRS-1893 Tablets in Healthy Subjects and Those With Impaired Kidney Function". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06775834. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*